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Background
In peanut-allergic patients, specific immunotherapy
using peanut extract has been shown to be associated
with significant side effects. Chemically modified aller-
gens may provide a safer alternative.
Methods
Purified native peanut conglutin, containing Ara h2 and
Ara h6, was chemically modified by reduction and alky-
lation (RA), without or with additional glutaraldehyde
treatment (RAGA). Serum of 14 peanut allergic patients
(DBPCFC-confirmed) was analyzed for peanut-specific
antibodies by IgE immunoblot and IgE/IgG1/IgG4
ELISA. Allergen-induced basophil activation was ana-
lyzed by direct basophil activation test (BAT), using
whole blood and washed whole blood to remove the
plasma. Native conglutin-specific T cell lines were ana-
lyzed for proliferation and cytokine production.
Results
IgE binding on immunoblot and IgE, IgG1 and IgG4
binding by ELISA to RA and RAGA was significantly
reduced compared to native conglutin. In most patients,
whole blood basophil activation by RA and RAGA was
reduced compared to native conglutin. In 4 patients,
modification did not result in a reduced basophil
response. These 4 patients had significantly higher levels
of native conglutin-specific IgG1 (ELISA) compared to
the other 10 patients. Upon washing of whole blood, the
response to native protein increased. The response to
RA and RAGA remained unchanged and was now
reduced compared to native conglutin in all patients. T
cell proliferation to RA was unchanged, and to RAGA
reduced as compared to native conglutin. Levels of cyto-
kines (IL-13, IFN-g, TNF-a) correlated with prolifera-
tion. No IL-10 production was observed.
Conclusions
Modification of peanut conglutin overall reduces IgE/
IgG binding. Allergen-induced basophil activation is
reduced in most patients. In some patients, the whole
blood basophil response to RA and RAGA is relatively
stronger than to native conglutin, which may be due to
inhibitory IgG1 antibodies that suppress the response to
native conglutin. T cell immunogenicity is retained,
especially to RA. This shows that chemical modification
may be a promising approach for the development of
immunotherapy for peanut allergy.
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